💬In plain words
What the trial is, and whether it could suit you
Malnutrition and anemia are common among people with chronic kidney disease who receive maintenance hemodialysis. These conditions may worsen health outcomes and quality of life. Intradialytic parenteral nutrition (IDPN) provides nutrients through a vein during hemodialysis and may be used when dietary intake is not sufficient. However, evidence on IDPN containing only amino acids, particularly in adults undergoing hemodialysis in Indonesia, remains limited.
This retrospective observational study will evaluate whether a 7.2% amino acid solution (KIDMIN®) given as IDPN is associated with improved nutritional status in adults with chronic kidney disease receiving maintenance hemodialysis. Medical records from Bangli Medika Canti Hospital covering July 2023 through December 2024 will be reviewed. Patients who received KIDMIN® during hemodialysis for at least 3 months will be compared with
Sign in to get the eligibility rules as simple questions to take to your doctor.
📋 Eligibility rules (as published)
Inclusion Criteria:
1. Age ≥ 18 years.
2. Outpatients undergoing maintenance hemodialysis at Bangli Medika Canti Hospital who are clinically stable and are not experiencing any acute condition.
3. Confirmed malnutrition, defined as a condition resulting from insufficient or imbalanced intake of energy, protein, and/or other nutrients, which may adversely affect body composition, physical and mental function, and clinical outcomes, and meeting all of the following criteria within 1-7 days:
* Body Mass Index (BMI) less than 18.5 kg/m2
* Mid-upper arm circumference (MUAC) less than 24.5 cm
* Serum pre-albumin level less than 16 mg/dL
4. Confirmed anemia, defined as a hemoglobin (Hb) concentration below the normal reference range within 1-7 days, specifically an Hb level of less than 13.0 g/dL in male patients or less than 12.0 g/dL in female patients.
5. At least 3 months of maintenance haemodialysis with duration of 3-4 hours per session, 2-3 times per week.
6. Provision of written informed consent prior to enrollment in this study (patient is available, can be contacted and approached).
Exclusion Criteria:
1. Patients who are hospitalized at the time of data collection or who require hospitalization during the observation period.
2. History of acute bleeding at the time of admission or requiring blood transfusion.
3. Patients with clinically evident edema or fluid overload.
4. Patients receiving other enteral or parenteral nutritional support concomitantly during observation period.
5. Patients who had received IDPN before observation period
6. Patients who have received IDPN in other dialysis clinic/facilities before transferring to Bangli Medika Canti Hospital will be excluded from the study.
7. Patients for whom the data required to evaluate the primary endpoint are unavailable.
8. Patients with duplicate enrollment in the same study protocol.
9. Patients who receive albumin administration during study period.
Bangli Medika Canti Hospital
Bangli, Indonesia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
HealthTeky